source
- MPM BioImpact adds three China-origin drug programs to K2 Therapeutics portfolioMPM BioImpact, a biotech investment firm, is intensifying its "best of both worlds" approach by bringing drug candidates that originated in China to a broader market. Over the past year its portfo…
- Medical students debate how to improve nutrition and preventive health training in med schoolsThe article is an opinion piece that examines medical students' views on Health Secretary Robert F. Kennedy's call for stronger nutrition and preventive medicine education in medical school. It fe…